Aeterna Zentaris Announces Reverse Stock Split Effective Date

TL;DR

Aeterna Zentaris is doing a reverse stock split, effective May 1, 2024.

AI Summary

Aeterna Zentaris Inc. announced on May 1, 2024, the effective date of its previously announced share consolidation, also known as a reverse stock split. This action will consolidate issued and outstanding common shares into a smaller number of shares.

Why It Matters

A reverse stock split can impact a company's stock price and trading dynamics, potentially making it more attractive to institutional investors.

Risk Assessment

Risk Level: low — The filing is a routine announcement of a corporate action (reverse stock split) and does not contain new financial risks.

Key Players & Entities

• Aeterna Zentaris Inc. (company) — Registrant
• May 1, 2024 (date) — Effective date of share consolidation

FAQ

Filing Documents

• form6-k.htm (6-K) — 41KB
• ex99-1.htm (EX-99.1) — 33KB
• ex99-1_001.jpg (GRAPHIC) — 5KB
• ex99-2.htm (EX-99.2) — 2KB
• ex99-2_001.jpg (GRAPHIC) — 131KB
• ex99-2_002.jpg (GRAPHIC) — 140KB
• ex99-2_003.jpg (GRAPHIC) — 102KB
• 0001493152-24-017445.txt ( ) — 598KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-38064 Aeterna Zentaris Inc. (Translation of registrant’s name into English) c/o Norton Rose Fulbright Canada, LLP, 222 Bay Street, Suite 3000, PO Box 53, Toronto ON M5K 1E7, Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F On May 1, 2024, Aeterna Zentaris Inc. (“Aeterna”) issued a news release announcing the effective date of the previously announced share consolidation (reverse stock split) (the “Consolidation”) of its issued and outstanding common shares (“Common Shares”) on the basis of one post-Consolidation Common Share for every four pre-Consolidation Common Shares. The Consolidation was approved by shareholders of Aeterna at the Company’s special meeting of shareholders held on March 12, 2024 along with other matters related to the merger of equals transaction with Ceapro Inc. (“Ceapro”) pursuant to a plan of arrangement (the “Plan of Arrangement”). The Common Shares are expected to continue trading on the TSX and the NASDAQ following the Consolidation under Aeterna’s existing symbol “AEZS” but have been assigned a new CUSIP number, which is 007975600. A copy of the news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. On April 30, 2024, Aeterna filed Articles of Amendment to its Restated Articles of Incorporation to effectuate the Consolidation in accordance with the Canada Business Corporations Act (the “Articles of Amendment”). A copy of the Articles of Amendment is attached hereto as Exhibit 99.2 and is incorporated herein by reference. This Report on Form 6-K and Exhibits 99.1 and 99.2 included with this Report on Form 6-K are hereby incorporated by reference into Aeterna’s Registration Statements on Forms S-8 (No. 333-224737, No. 333-210561 and No. 333-200834) and Form F-3 (No. 333-254680) (collectively, the “Registration Statements”) and shall be deemed to be a part thereof from the date on which this Report on Form 6-K is furnished, to the extent not superseded by documents or reports subsequently filed or furnished. The information contained on any websites referenced in Exhibit 99.1 included with this Report on Form 6-K is not incorporated by reference or deemed to be a part of this Report on Form 6-K or any of the Registration Statements. Aeterna has filed a Registration Statement on Form F-1 (including a prospectus) (File No. 333-277115) (the “Form F-1 Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) for the issuance of common share purchase warrants and Common Shares issuable upon exercise thereof in connection with the Plan of Arrangement, but it has not yet become effective. The common share purchase warrants and Common Shares issuable upon the exercise thereof may not be sold nor may offers to buy them be accepted prior to the time the Form F-1 Registration Statement becomes effective. Before you invest in any Common Shares, you should read the prospectus in the Form F-1 Registration Statement and the other documents incorporated by reference therein for more complete information about Aeterna, Ceapro, the Transaction and the common share purchase warrant offering. You may get copies of the Form F-1 Registration Statement for free by visiting EDGAR on the SEC website at www.sec.gov or at SEDAR+ at www.sedarplus.ca. Alternatively, you may obtain copies of them by contacting the following: Aeterna’s Proxy Solicitor Kingsdale Advisors 1-866-581-1513 (North American Toll Free) or 416-623-2513 (Outside North America — text and call enabled) contactus@kingsdaleadvisors.com www.AEZSmerger.com Media Contact Joel Shaffer FGS Longview joel.shaffer@fgslongview.com 416-670-6468 No Offer or Solicitation This Report on Form 6-K and the exhibit attached hereto and incorporated by reference herein, and the information contained herein and therein are not, and do not, constitute an offer to sell any securities or a solicitation of an offer to buy any securities in the United States or any other state or jurisdiction, nor shall any securities of Aeterna be offered or sold in any jurisdiction in which such an offer, solicitation or sale would be unlawful. Neither the SEC nor any state securities commission has approved or disapproved of the transactions described herein or determined if this communication is truthful or complete. Any representation to the contrary is a criminal offense. You should not construe the contents of this Report on Form 6-K or the e

View Full Filing

View this 6-K filing on SEC EDGAR